ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Taiwan Liposome Company Ltd

Taiwan Liposome Company Ltd (TLC)

7.00
0.00
(0.00%)
Cerrado 17 Diciembre 3:00PM
7.00
0.00
( 0.00% )
Pre Mercado: 6:00PM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
7.00
Postura de Compra
6.66
Postura de Venta
7.10
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
7.00
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

TLC Últimas noticias

Highlights of Dr. David Hunter’s Oral Presentation at ACR’s Late Breaking Abstracts Session

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Professor David Hunter, Florance and Cope Chair of Rheumatology at the University of Sydney, presented detailed...

TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACR

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 08, 2023 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a late clinical-stage specialty pharmaceutical company developing novel nanomedicines to...

TLC Announces TLC599 Agreement with Endo

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 13, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...

TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & Therapy

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, March 07, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target...

TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares

This communication does not constitute an offer of any securities for sale or subscription or a solicitation of an offer to purchase or subscribe to any securities in any jurisdiction. The...

TLC Reports Second Quarter 2021 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Aug. 12, 2021 (GLOBE NEWSWIRE) -- TLC, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet...

TLC Announces Details of Stock Swap Transactions

TAIPEI, Taiwan, July 05, 2021 (GLOBE NEWSWIRE) -- Taiwan Liposome Company (Nasdaq: TLC, TWO: 4152, “the company”), a clinical-stage specialty pharmaceutical company developing novel...

TLC and Zydus Enter Agreement to Launch AmphoTLC™ in India

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 26, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...

TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in India

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 25, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...

InspirMed Highlights Encouraging Data on ISPM21 and ISPM19 – Inhalable Liposome Formulations of Antiviral Drugs for COVID-1...

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 23, 2021 (GLOBE NEWSWIRE) -- InspirMed Inc., a subsidiary of TLC (Nasdaq: TLC, TWO: 4152) that specializes in the development of proprietary...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PLRZPolyrizon Ltd
US$ 3.01
(186.67%)
18.99M
LITMSnow Lake Resources Ltd
US$ 0.442
(141.53%)
37.5M
VSTEVast Renewable Ltd
US$ 2.89
(122.31%)
35.69M
NUKKNukkleus Inc
US$ 18.15
(52.78%)
2.67M
PRZOParaZero Technologies Ltd
US$ 2.29
(49.67%)
11.56M
DHAIDIH Holdings US Inc
US$ 0.90
(-34.78%)
15
FTELFitell Corporation
US$ 27.84
(-27.48%)
571
NIVFNewGenIvf Group Ltd
US$ 0.3159
(-25.44%)
367.63k
PTPIPetros Pharmaceuticals Inc
US$ 0.379
(-24.20%)
1.21M
HTBKHeritage Commerce Corporation
US$ 8.01
(-20.54%)
1
LITMSnow Lake Resources Ltd
US$ 0.442
(141.53%)
37.5M
CEROCERo Therapeutics Holdings Inc
US$ 0.085
(39.12%)
37.09M
VSTEVast Renewable Ltd
US$ 2.89
(122.31%)
35.69M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.4345
(30.13%)
29.51M
PLRZPolyrizon Ltd
US$ 3.01
(186.67%)
18.99M

TLC Discussion

Ver más
TraderStig TraderStig 3 años hace
#DDAmanda Chart on: $TLC

You can scan for these before they run.



#DDAmanda Promo Code: dsh888

What the Fact (Factor) Column is:

The Factor is a proprietary indicator used for scanning in #DDAmanda.

It's defined as Today's $Traded divided by the average daily $Traded (20 day avg).

SO, if a stock has say a 10 Factor that day, it means she traded 10 Times the $ she normally trades.

That's significant, and many times indicates that a run in the stock is coming.




👍️0
FROZENFLAME FROZENFLAME 4 años hace
$TLC READY FOR SOME NEWS .
👍️0
FROZENFLAME FROZENFLAME 4 años hace
$$$TLC$$$
👍️0
FROZENFLAME FROZENFLAME 4 años hace
https://ir.tlcbio.com/news-releases/news-release-details/tlc-announces-acceptance-manuscript-anti-covid-19-program
👍️0
FROZENFLAME FROZENFLAME 4 años hace
Nice close .
👍️0
FROZENFLAME FROZENFLAME 4 años hace
Hit me with the NEWS !!
👍️0
FROZENFLAME FROZENFLAME 4 años hace
4 weeks almost over, hydroxychloroquine. Study medication is administered through inhalation via a commercially available portable vibrating mesh nebulizer, and all subjects will be followed up for 4 weeks.
👍️0
FROZENFLAME FROZENFLAME 4 años hace
Adding .
👍️0
FROZENFLAME FROZENFLAME 4 años hace
This my baby, I’m adding more tomorrow .
👍️0
FROZENFLAME FROZENFLAME 4 años hace
https://ir.tlcbio.com/news-releases/news-release-details/tlc-announces-appointment-thomas-h-bliss-jr-mba-chief-business
👍️0
FROZENFLAME FROZENFLAME 4 años hace
Adding some more, updates coming soon .
👍️0
FROZENFLAME FROZENFLAME 4 años hace
O/S 5M one more update $10s will be up with no time .
👍️0
FROZENFLAME FROZENFLAME 4 años hace
https://finance.yahoo.com/news/tlc-enrolls-first-subject-phase-084100428.html
👍️0
FROZENFLAME FROZENFLAME 4 años hace
4K shares at $9.00 after hours !!!!
👍️0
FROZENFLAME FROZENFLAME 4 años hace
Huge potential !!!
👍️0
FROZENFLAME FROZENFLAME 4 años hace
Nice close .
👍️0
FROZENFLAME FROZENFLAME 4 años hace
I’m in $$$TLC$$$
👍️0
crudeoil24 crudeoil24 4 años hace

TLC Receives Australian and Taiwan Approval to Initiate Phase I Clinical Trial of TLC19 Inhalable Liposomal Hydroxychloroquine for COVID-19
👍️0
otcmoneydoubler otcmoneydoubler 4 años hace
TLC MOVING ON COVID AUSTRALIAN NEWS
👍️0